IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...

ADA: Beta Bionics' automated insulin pump slashes glucose levels, diabetes distress in Type 1 patients By Andrea Park Jun 10, 2022 1:35pm ...

On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s future dual glucose-ketone sensor in the US.

Loss of beta cell function serves as the basis for progression from normal glucose tolerance to impaired glucose tolerance, but insulin clearance may not be a major factor in the development of ...

In a groundbreaking study, a research team at KAIST has uncovered a gut-brain circuit that enables the brain to selectively ...

ADA: Beta Bionics' automated insulin pump slashes glucose levels, diabetes distress in Type 1 patients The latest funding round easily tops Beta Bionics’ series C, which brought in $57 million ...

Recent advances in glucose management are reshaping our understanding of cognitive decline and dementia prevention. Energy ...

On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s future dual glucose-ketone sensor in the US.

Scientists have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells. These significant findings open the door ...

Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have confirmed the existence of progenitor cells within the human pancreas that can be ...